Original site: www.cdc.gov/la-crosse-encephalitis/hcp/clinical-signs/index.html | RestoredCDC.org is an independent project, not affiliated with CDC or any federal entity. Visit CDC.gov for free official information. Due to archival on January 6, 2025, recent outbreak data is unavailable. Videos are not restored. Access data.restoredcdc.org for restored data. Use of this site implies acceptance of this disclaimer.

[More]
About Us Report Bug

RestoredCDC.org Comparison

Removed: Line removed from cdc.gov. Specific word removals are highlighted.
Added: Line added to cdc.gov. Specific word additions are highlighted.
Injected: Line or disclaimer added by RestoredCDC.org.
Unchanged: Line unchanged.
Original site: www.cdc.gov/la-crosse-encephalitis/hcp/clinical-signs/index.html | RestoredCDC.org is an independent project, not affiliated with CDC or any federal entity. Visit CDC.gov for free official information. Due to archival on January 6, 2025, recent outbreak data is unavailable. Videos are not restored. Access data.restoredcdc.org for restored data. Use of this site implies acceptance of this disclaimer.
[More]
About Us Report Bug Compare Content
Skip directly to site content Skip directly to search Skip directly to On This Page
An official website of the United States government
Here's how you know
Official websites use .gov
A .gov website belongs to an official government organization in the United States.
Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.
La Crosse Virus
Explore Topics
Search
Search
Clear Input
For Everyone
* About
* Causes and Spread
* Prevention
* Data and Maps
* Leah's Story
* Illness Info
* View all
Health Care Providers
* Clinical Signs and Symptoms
* Clinical Testing and Diagnosis
* Treatment and Prevention
* View all
Public Health
* Transmission
* Resources
* Communication Resources
* View all
Related Topics:
Vector-Borne Diseases
View All
search close search
search
La Crosse Virus Menu Close
La Crosse Virus Menu
search
For Everyone
* About
* Causes and Spread
* Prevention
* Data and Maps
* Leah's Story
* Illness Info
* View All
Health Care Providers
* Clinical Signs and Symptoms
* Clinical Testing and Diagnosis
* Treatment and Prevention
* View All
Public Health
* Transmission
* Resources
* Communication Resources
* View All
Related Topics
* Vector-Borne Diseases
View All La Crosse Virus
Clinical Signs and Symptoms Clinical Testing and Diagnosis Treatment and Prevention View All
May 15, 2024
Clinical Signs and Symptoms of La Crosse Virus Disease
Key Points
* La Crosse virus disease can present as an acute febrile illness or neuroinvasive disease.
* The incubation period for La Crosse virus disease ranges from 5–15 days.
* Most patients with La Crosse virus neuroinvasive disease survive; approximately 1% of cases are fatal and 6–15% have neurologic sequelae.
Clinical presentation
La Crosse virus disease should be considered in any person with an acute febrile or neurologic illness who has had recent exposure to mosquitoes, especially during the summer months in endemic areas of the United States. La Crosse virus disease is most common in children under the age of 16 years.
Other causes of encephalitis and aseptic meningitis should also be considered, as appropriate (e.g., herpes simplex viruses, enteroviruses, West Nile virus, St. Louis encephalitis virus, Jamestown Canyon virus, Powassan virus).
Signs and symptoms
Most La Crosse virus infections are clinically inapparent, and the vast majority of infections remain undiagnosed. The incubation period for La Crosse virus disease ranges from 5 to 15 days.
Initial symptoms include fever, headache, nausea, vomiting, fatigue, and lethargy. The disease can progress to encephalitis, meningoencephalitis, or aseptic meningitis. Symptoms of encephalitis can include altered mental status, seizures, speech problems (aphasia, dysarthria), paresis or paralysis, movement disorders, and cranial nerve palsies. La Crosse virus infection has not been associated with acute flaccid paralysis.
Clinical assessment
In acute La Crosse virus neuroinvasive disease cases, cerebrospinal fluid (CSF) examination typically shows a mildly elevated white blood cell count and normal glucose; CSF protein is elevated in about one third of cases. The peripheral white blood cell count is usually elevated. Computed tomography (CT) brain scans are usually normal, while electroencephalographic (EEG) abnormalities are more common. EEG results often resemble those seen in cases of herpes simplex encephalitis.
Outcomes
Approximately 1% of La Crosse virus neuroinvasive disease cases are fatal. Neurologic sequelae, including epilepsy, hemiparesis, and cognitive and neurobehavioral abnormalities, have been reported in 6%−15% of cases.
On This Page
* Clinical presentation
* Signs and symptoms
* Clinical assessment
* Outcomes
Related PagesClinical Testing and Diagnosis
Related Pages
*
* View All
Back to Top
* Clinical Testing and Diagnosis
* Treatment and Prevention
View All La Crosse Virus
Clinical Testing and Diagnosis
May 14, 2024
Sources Print Share
Facebook LinkedIn Twitter Syndicate
Content Source:
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Sources
* Vahey GM, Lindsey NP, Staples JE, Hills SL. La Crosse Virus Disease in the United States, 2003-2019. Am J Trop Med Hyg. 2021;105(3):807-812. doi: 10.4269/ajtmh.21-0294
* Hennessey MJ, Pastula DM, Machesky K, Fischer M, Lindsey NP, DiOrio M, et al. Investigation of acute flaccid paralysis reported with La Crosse virus infection, Ohio, USA, 2008–2014. Emerg Infect Dis. 2017;23(12):2075-2077. doi: 10.3201/eid2312.170944
* Gaensbauer JT, Lindsey NP, Messacar K, Staples JE, Fischer M. Neuroinvasive arboviral disease in the United States: 2003 to 2012. Pediatrics. 2014;134(3):e642-50. doi: 10.1542/peds.2014-0498
* de los Reyes EC, McJunkin JE, Glauser TA, Tomsho M, O'Neal J. Periodic lateralized epileptiform discharges in La Crosse encephalitis, a worrisome subgroup: clinical presentation, electroencephalogram (EEG) patterns, and long-term neurologic outcome. J Child Neurol. 2008;23:167-172. doi: 10.1177/0883073807307984
* Haddow AD and Odoni A. The Incidence risk, clustering, and clinical presentation of La Crosse virus infections in the eastern United States, 2003–2007. PLoS ONE, 2007; 4(7): e6145. doi: 10.1371/journal.pone.0006145
* Hardin SG, Erwin PC, Patterson L, New D, Graber C, Halford SK. Clinical comparisons of La Crosse encephalitis and enteroviral central nervous system infections in a pediatric population: 2001 surveillance in East Tennessee. Am J Infect Control. 2003;31:508-510. doi: 10.1016/s0196-6553(03)00084-1
* McJunkin JE, de los Reyes EC, Irazuzta JE, Caceres MJ, Khan RR, Minnich LL, et al. La Crosse encephalitis in children. N Engl J Med. 2001;344:801-807. doi: 10.1056/NEJM200103153441103
* Sokol DK, Kleiman MB, Garg BP. La Crosse viral encephalitis mimics herpes simplex viral encephalitis. Pediatr Neurol. 2001;25:413-415. doi: 10.1016/s0887-8994(01)00337-x
* Byrd BD, Williams CJ, Staples JE, Burkhalter KL, Savage HM, Doyle MS. Notes from the field: Spatially associated coincident and noncoincident cases of La Crosse encephalitis – North Carolina, 2002-2017. MMWR Morb Mortal Wkly Rep. 2018;67(39):1104-1105. doi: 10.15585/mmwr.mm6739a8
Related PagesClinical Testing and Diagnosis
Related Pages
*
 
* View All
* Clinical Testing and Diagnosis
* Treatment and Prevention
View All La Crosse Virus
Back to Top
La Crosse Virus
La Crosse virus is spread by mosquitoes. Learn about areas at risk, the illness it causes, and ways to prevent becoming infected.
View All
For Everyone
* About
* Causes and Spread
* Prevention
* Data and Maps
* Leah's Story
* Illness Info
Health Care Providers
* Clinical Signs and Symptoms
* Clinical Testing and Diagnosis
* Treatment and Prevention
Public Health
* Transmission
* Resources
* Communication Resources
Sign up for Email Updates
Contact Us
Contact Us
* Call 800-232-4636
* Contact CDC
About CDC
About CDC
* Pressroom
* Organization
* Budget & Funding
* Careers & Jobs
Policies
* Accessibility
* External Links
* Privacy
* Web Policies
* FOIA
* OIG
* No Fear Act
* Nondiscrimination
* Vulnerability Disclosure Policy
Languages
Languages
* Español
Language Assistance
* Español
* 繁體中文
* Tiếng Việt
* 한국어
* Tagalog
* Русский
* العربية
* Kreyòl Ayisyen
* Français
* Polski
* Português
* Italiano
* Deutsch
* 日本語
* فارسی
* English
Archive
* CDC Archive
* Public Health Publications
Contact Us
Contact Us
* Call 800-232-4636
* Contact CDC
About CDC
* Pressroom
* Organization
* Budget & Funding
* Careers & Jobs
* About CDC
Policies
* Accessibility
* External Links
* Privacy
* Web Policies
* FOIA
* OIG
* No Fear Act
* Nondiscrimination
* Vulnerability Disclosure Policy
Languages
Languages
* Español
Language Assistance
* Español
* 繁體中文
* Tiếng Việt
* 한국어
* Tagalog
* Русский
* العربية
* Kreyòl Ayisyen
* Français
* Polski
* Português
* Italiano
* Deutsch
* 日本語
* فارسی
* English
Archive
* CDC Archive
* Public Health Publications
HHS.gov USA.gov
Note: Comparison ignores leading/trailing whitespace and certain script/tracking codes. Word-level highlighting (optional above) only applies to changed lines.